HotMed.info

Olanzapine

Olanzapine (Zyprexa, Zyprexa Zydis, Zalasta, Zolafren, Olzapin, or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA for the treatment of: schizophrenia on 1996-09-30 [1]; depressive episodes associated with bipolar disorder, as part of the Symbyax formulation, on 2003-12-24[2]; acute manic episodes and maintenance treatment in bipolar disorder on 2004-01-14[3]. Off-label [...]

Continue reading...